|
India
or China?
Indian and Chinese pharmaceutical markets might pose tough
competition for each other, but at the same time, both are
promising yet challenging bets for the global pharma industry.
Sushmi Dey compares these two pharma markets on the basis
of their distinctive features
Destination
China
Multinational pharmaceutical companies are now eyeing the
Chinese pharma market not only for APIs or manufacturing services
but also for research operations. Undoubtedly, winds are changing
for the Chinese drug industry. Sushmi Dey finds out more about
these plethora of changes in conversation with Hu Kun Ping,
Vice-President, Reed Sinopharm Exhibitions who recently organised
API and INTERPHEX China in Shenzhen…
Novartis
India recognised for contributing in rehabilitating leprosy
patients
Novartis India received the Reader's Digest Pegasus CSR Gold
Award in the category 'Contribution to Individual Welfare'
on December 12.
Bilcare
inaugurates Centre of Excellence; launches a unique CSR project
Former President of India, Dr APJ Abdul Kalam and Dr John
L LaMattina, Senior Vice-President, Pfizer, and President,
Pfizer Global Research and Development, inaugurated the Bilcare
Centre of Excellence along with a unique product developed
by Bilcare to combat the global crisis of counterfeiting,
in Pune.
Aurobindo
gets US nod for cefdinir antibiotic
The US Food and Drug Administration has approved Aurobindo
Pharma's antibiotic cefdinir in the oral suspension form,
according to the regulator's Web site.
Suven
Life to raise $30 million by March
Suven Life Sciences plans to raise up to $30 million by March
via an issue of shares to private equity and a convertible
bond issue to fund its drug discovery programme, boosting
its shares, an official said.
Kolkata
to host IAPST international conference on drug delivery
Kolkata will be hosting the first international conference
on drug delivery and drug targeting research.
Non
invasive nano could be the way ahead
"Injectable formulations from elsewhere is not readily
accepted in the West," revealed Dr Amarnath Maitra, while
addressing a discussion on nano-biotechnology and nano-medicine
during the first ever dedicated event on nanotechnology in
India, Bangalore Nano, on the 6th and 7th December, 2007.
FICCI-
Safexpress meet discusses retail sector opportunities
Safexpress, in association with Federation of Indian Chambers
of Commerce and Industry (FICCI), did the valedictory session
at CEO's Conclave for the two-day long global conference "Winning
with Intelligent Supply Chains- WISC 2007".
Events
Brief
More
than just a mile
The CRO industry's growth is spawning a host of clinical research
training institutes. The new-kid-on-the-block is Clinical
Research Institute (CRI), with Vijay Moza as Director. He
talks to Garima Arora, on the USP of CRI and the competition
in the clinical research education arena
|
